Walnut Hill Medical is pleased to announce that David Kravitz, CEO of Organ Recovery Systems, has joined its Board of Directors. With decades of experience in medical technology development, organ transplantation, and healthcare innovation, Mr. Kravitz will provide valuable strategic guidance as Walnut Hill Medical continues its mission of improving patient access to breakthrough treatments.
Health Technology Insights: Alignment Healthcare Boosts AI Medicare Team with New Leaders
Mr. Kravitz is a recognized leader in transplantation medtech. In 1998, he founded Organ Recovery Systems, a company dedicated to improving outcomes in transplantation by enhancing donor organ preservation, evaluation, and transportation. Under his leadership, the company developed and commercialized the groundbreaking LifePort Kidney Transporter, a clinical standard of care in renal transplant centers worldwide. This innovation has significantly improved kidney transplant outcomes by enabling recovery of donor organs previously considered not transplantable, lowering the risk of post-transplant complications and hospitalization, improving long-term graft survival, and supporting renal transplant as a scheduled surgery vs. emergent procedure.
Beyond his leadership at Organ Recovery Systems, Mr. Kravitz is a co-inventor of several dozen medical technology patents and has founded multiple medical device companies focused on improving patient care. In recognition of his contributions, he was named to Fast Company magazine’s “Fast 50” list of global entrepreneurs and innovators in 2004.
Health Technology Insights: Healthcare IT Today and the Alliance for Smart Healthcare Excellence Unveil SmartHealthcareTech.com
His passion for organ transplantation is deeply personal—his father received a lifesaving heart transplant in the 1990s, inspiring Mr. Kravitz to dedicate his career to improving transplant success rates. His work has helped shape modern transplant medicine, ensuring that more patients have access to viable, well-preserved organs.
“I am honored to join the Board of Directors at Walnut Hill Medical,” said Mr. Kravitz. “Healthcare innovation and patient-centered care have always been at the core of my work, and I look forward to contributing my expertise to further the company’s mission.”
Chris Hanna, the CEO of Walnut Hill Medical, added, “David Kravitz is a true innovator in the field of organ transplantation. His leadership, vision, and groundbreaking work in medical technology will be invaluable as we continue to expand our services and improve patient access to innovative therapies.”
Health Technology Insights: NanoSpeed Diagnostics Receives Health Canada Approval for Test4D Test
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – PR Newswire
